Intrarectal Immunization with Rotavirus 2/6 Virus-Like Particles Induces an Antirotavirus Immune Response Localized in the Intestinal Mucosa and Protects against Rotavirus Infection in Mice
- 15 April 2006
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 80 (8), 3823-32
- https://doi.org/10.1128/jvi.80.8.3823-3832.2006
Abstract
Rotavirus (RV) is the main etiological agent of severe gastroenteritis in infants, and vaccination seems the most effective way to control the disease. Recombinant rotavirus-like particles composed of the viral protein 6 (VP6) and VP2 (2/6-VLPs) have been reported to induce protective immunity in mice when administered by the intranasal (i.n.) route. In this study, we show that administration of 2/6-VLPs by the intrarectal (i.r.) route together with either cholera toxin (CT) or a CpG-containing oligodeoxynucleotide as the adjuvant protects adult mice against RV infection. Moreover, when CT is used, RV shedding in animals immunized by the i.r. route is even reduced in comparison with that in animals immunized by the i.n. route. Humoral and cellular immune responses induced by these immunization protocols were analyzed. We found that although i.r. immunization with 2/6-VLPs induces lower RV-specific immunoglobulin G (IgG) and IgA levels in serum, intestinal anti-RV IgA production is higher in mice immunized by the i.r. route. Cellular immune response has been evaluated by measuring cytokine production by spleen and Peyer's patch cells (PPs) after ex vivo restimulation with RV. Mice immunized by the i.n. and i.r. routes display higher gamma interferon production in spleen and PPs, respectively. In conclusion, we demonstrate that i.r. immunization with 2/6-VLPs protects against RV infection in mice and is more efficient than i.n. immunization in inducing an anti-RV immune response in intestinal mucosa.Keywords
This publication has 38 references indexed in Scilit:
- Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particlesEuropean Journal of Immunology, 2005
- Characterization of Homologous and Heterologous Rotavirus-Specific T-Cell Responses in Infant and Adult MiceJournal of Virology, 2005
- Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNAImmunology Letters, 2004
- Immunotherapeutic uses of CpG oligodeoxynucleotidesNature Reviews Immunology, 2004
- Comparison of different routes of vaccination for eliciting antibody responses in the human stomachVaccine, 2004
- The Role of Interferons in Rotavirus Infections and ProtectionJournal of Interferon & Cytokine Research, 2003
- Heterologous Protection Induced by the Inner Capsid Proteins of Rotavirus Requires Transcytosis of Mucosal ImmunoglobulinsJournal of Virology, 2002
- Lack of a Role for Type I and Type II Interferons in the Resolution of Rotavirus-Induced Diarrhea and Infection in MiceJournal of Interferon & Cytokine Research, 1999
- Functional diversity of helper T lymphocytesNature, 1996
- Identification of cytotoxic T cell epitopes on the VP3 and VP6 rotavirus proteinsJournal of General Virology, 1994